Max K.
- Country
- Finland
- Department
- CRST Oy - Clinical Research Services Turku Oy
Research Overview
- Safety and Tolerability Assessment of TEV-53408 in Adult Patients with Celiac Disease: A Phase 1b Clinical Trial
- Phase I Double-Blind Randomized Placebo-Controlled Study on Safety and Pharmacokinetics of KAND145 in Healthy Volunteers with Ovarian Cancer
- Efficacy and Tolerability of ZED1227 in Patients with Celiac Disease Experiencing Symptoms Despite a Gluten-Free Diet: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial
Data & Insights
Has run more than one trial at 36 of 153 partner sites.
Specializations
Gastroenterology Focus
This investigator demonstrates significant expertise in celiac disease treatment and management, with particular attention to novel therapeutic approaches for patients with persistent symptoms.
- Non-responsive celiac disease interventions
- Gluten-free diet optimization
- Intestinal mucosal health
The research encompasses innovative treatments for improving duodenal histology and symptom management in celiac patients.
Metabolic Health
The investigator specializes in metabolic disorders and weight management therapies, with a focus on treating complex metabolic conditions.
- Type 2 diabetes management
- Obesity treatment
- Brown fat activation studies
Their work includes investigating combined approaches to weight loss and metabolic regulation.
Oncology Research
The investigator conducts research in gynecologic oncology, with particular emphasis on developing new therapeutic approaches for ovarian cancer.
- Ovarian cancer therapeutics
- Novel drug development
- Treatment safety assessment
The research focuses on evaluating innovative therapeutic compounds for gynecological cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.